Some studies described the inhibitory action of adiponectin on breast cancer cell growth by the up-regulation of p53, p21 and Bax and/or the reduced expression of c-myc, cyclin D, and Bcl-2 levels (78, 119, 120). The gene discussed is ADIPOQ; the disease is breast carcinoma.